GREGORATOS
ET AL., ACC/AHA/NASPE 2002 Guideline Update for Implantation
of Cardiac Pacemakers and Antiarrhythmia Devices
http://www.acc.org/clinical/guidelines/pacemaker/index.htm;
2002
ACC/AHA/NASPE
2002 Guideline Update for Implantation of Cardiac Pacemakers
and Antiarrhythmia Devices—Full
Text
A
Report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (ACC/AHA/NASPE
Committee on Implantation)
Committee
Members
Gabriel
Gregoratos, MD, FACC, FAHA, Chair; Jonathan Abrams, MD, FACC,
FAHA; Andrew E. Epstein, MD, FACC, FAHA; Roger A. Freedman,
MD, FACC; David L. Hayes, MD, FACC, FAHA; Mark A. Hlatky,
MD, FACC, FAHA; Richard E. Kerber, MD, FACC, FAHA; Gerald
V. Naccarelli, MD, FACC, FAHA; Mark H. Schoenfeld, MD, FACC,
FAHA; Michael J. Silka, MD, FACC; Stephen L. Winters, MD,
FACC
Task
Force Members
Raymond
J. Gibbons, MD, FACC, FAHA, Chair; Elliott M. Antman, MD,
FACC, FAHA, Vice Chair; Joseph S. Alpert, MD, FACC, FAHA;
David P. Faxon, MD, FACC, FAHA; Valentin Fuster, MD, PhD,
FACC, FAHA; Gabriel Gregoratos, MD, FACC, FAHA; Loren F. Hiratzka,
MD, FACC, FAHA; Alice K. Jacobs, MD, FACC, FAHA; Sidney C.
Smith, Jr., MD, FACC, FAHA
Table
of Contents:
Preamble
Introduction
- Indications
for Permanent Pacing
- Pacing
for Acquired Atrioventricular Block in Adults
- Pacing
for Chronic Bifascicular and Trifascicular Block
- Pacing
for Atrioventricular Block Associated With Acute Myocardial
Infarction
- Pacing
in Sinus Node Dysfunction
- Prevention
and Termination of Tachyarrhythmias by Pacing
- Pacing
in Hypersensitive Carotid Sinus and Neurocardiogenic
Syncope
- Pacing
in Children, Adolescents, and Patients With Congenital
Heart Disease
- Pacing
in Specific Conditions
- Hypertrophic
Obstructive Cardiomyopathy
- Idiopathic
Dilated Cardiomyopathy
- Cardiac
Transplantation
- Selection
of Pacemaker Device
- Newer
Technical Innovations
- Methodology
of Comparing Different Pacing Modes
- Pacing
in Sinus Node Dysfunction
- Pacing
in Atrioventricular Block
- Pacing
in the Elderly
- Optimizing
Pacemaker Technology and Cost
- Pacemaker
Follow-up
- Amount
of Time Necessary for Verification
- Length
of Electrocardiographic Samples for Storage
- Frequency
of Transtelephonic Monitorin
-
Indications for Implantable Cardioverter-Defibrillator Therapy
- Background
- Clinical
Efficiency of ICD Therapy
- Alternatives
to ICD Therapy
- Comparison
of Drug and Device Therapy for Secondary Prevention
of Cardiac Arrest and Sustained Ventricular Tachycardia
- Specific
Disease States and Secondary Prevention of Cardiac Arrest
or Sustained VentricularTachycardia
- Coronary
Artery Disease
- Idiopathic
Dilated Cardiomyopathy
- Long-QT
Syndrome
- Idiopathic
Ventricular Fibrillation
- Idiopathic
Ventricular Tachycardia
- Hypertrophic
Cardiomyopathy
- Arrhythmogenic
Right Ventricular Dysplasia/Cardiomyopathy
- Syncope
With Inducible Sustained Ventricular Tachycardia
- Pediatric
Patients
- Primary
Prevention of Sudden Cardiac Death
- Coronary
Artery Disease
- After
Coronary Artery Bypass Surgery
- As
a Bridge to Heart Transplantation
- Other
Populations
- Contraindications
and Limitations of ICD Therapy
- Cost-Effectiveness
of ICD Therapy
- Selection
of ICD Generators
- ICD
Follow-up
- Elements
of ICD Follow-up
This
document was approved by the American College of Cardiology
Foundation Board of Trustees in September 2002, by the American
Heart Association Science Advisory and Coordinating Committee
in August 2002, and by the North American Society for Pacing
and Electrophysiology in August 2002.
When citing this document, the American College of Cardiology
Foundation, the American Heart Association, and the North
American Society of Pacing and Electrophysiology would appreciate
the following citation format: Gregoratos G, Abrams J, Epstein
AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli
GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002
guideline update for implantation of cardiac pacemakers and
antiarrhythmia devices: a report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation).
2002. Available at: www.acc.org/ clinical/guidelines/pacemaker/pacemaker.pdf.
This document is available on the World Wide Web sites of
the ACC (www.acc.org), the AHA (www.americanheart.org),
and the NASPE (www.naspe.org).
Copies of this document (the complete guidelines) are available
for $5 each by calling 800-253-4636 (US only) or writing the
American College of Cardiology, Educational Services, 9111
Old Georgetown Road, Bethesda, MD 20814-1699 (ask for No.
71-0237). To obtain a reprint of the shorter version (summary
article describing the changes to the guidelines) planned
for subsequent publication in J Am Coll Cardiol and
Circulation, ask for reprint No. 71-0236. To purchase
additional reprints (specify version and reprint number):
up to 999 copies, call 800-611-6083 (US only) or fax 413-665-
2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342,
or e-mail pubauth@heart.org.
©
2002 by the American College of Cardiology Foundation and
the American Heart Association, Inc.
|
